Bessemer Group
WGS icon

Bessemer Group’s GeneDx Holdings WGS Stock Holding History

Bessemer Group’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Hold
17
– – ﹤0.01% 2468
2025
Q4 		$2K Hold
17
– – ﹤0.01% 2442
2025
Q3 		$2K Buy
+17
New +$1.85K ﹤0.01% 2362

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bessemer Group's WGS Position: Q1 2026 in Review

Bessemer Group held its GeneDx Holdings (WGS) position steady in Q1 2026 at 17 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Bessemer Group first reported a position in WGS in Q3 2025 and has held it in 3 quarters since. The position peaked at $2K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Bessemer Group held 17 shares of GeneDx Holdings worth $1K as of Q1 2026.
  • Bessemer Group left its GeneDx Holdings share count unchanged in Q1 2026.
  • GeneDx Holdings made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #2468 holding.
  • Bessemer Group first reported a position in GeneDx Holdings in Q3 2025 and has held it in 3 quarters since.
  • Bessemer Group's GeneDx Holdings position peaked at $2K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.